Ming Ouyang

Detection of epidermal growth factor receptor mutations in plasma by mutant‐enriched PCR assay for prediction of the response to gefitinib in patients with non‐small‐cell lung cancer

Chen He, Ming Liu, Chengzhi Zhou et al. · International Journal of Cancer · 2009 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Worldwide malaria incidence and cancer mortality are inversely associated

Qin Li, Changzhong Chen, Lili Chen et al. · Infectious Agents and Cancer · 2017 · 57 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer

Xiaohong Xie, Liqiang Wang, Xinni Wang et al. · Frontiers in Oncology · 2021 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17

Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma

Xiaohong Xie, Liqiang Wang, Xinqing Lin et al. · Orphanet Journal of Rare Diseases · 2020 · 52 citations · Full text

Medicine, Oncology, Pathology +17

<p>Anlotinib Plus S-1 for Patients with EGFR Mutation-Negative Advanced Squamous Cell Lung Cancer with PS Scores of 2–3 After Progression of Second-Line or Later-Line Treatment</p>

Fei Wang, Xinqing Lin, Zhanhong Xie et al. · Cancer Management and Research · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +13